Targeting osteosarcopenia and multimorbidity for frailty prevention through identification and deep phenotyping methods in healthy ageing and high-burden disease cohorts (OPTIMA-C): a longitudinal observational cohort study protocol for neuromusculoskeletal muscle health

Introduction Sarcopenia and frailty have been identified as negative predictors of health outcomes. Patients with stroke, traumatic brain injury (TBI), knee osteoarthritis (OA) and breast cancer commonly experience low physical activity levels in the chronic phase of recovery. This prospective study...

Full description

Saved in:
Bibliographic Details
Main Authors: Keng He Kong, Eng Sing Lee, Wee Shiong Lim, Sai Zhen Sim, Bryan Yijia Tan, Matthew Rong Jie Tay, Jong Moon Kim, Poo Lee Ong, Lay Wai Khin, Chin Jung Wong, Michael Gui Jie Yam, Justin Linghui Chew, Alvin Wai Kit Tan, Ananda Sidarta, Emily Yee, Karen Sui Geok Chua
Format: Article
Language:English
Published: BMJ Publishing Group 2025-05-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/15/5/e094279.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849310026374578176
author Keng He Kong
Eng Sing Lee
Wee Shiong Lim
Sai Zhen Sim
Bryan Yijia Tan
Matthew Rong Jie Tay
Jong Moon Kim
Poo Lee Ong
Lay Wai Khin
Chin Jung Wong
Michael Gui Jie Yam
Justin Linghui Chew
Alvin Wai Kit Tan
Ananda Sidarta
Emily Yee
Karen Sui Geok Chua
author_facet Keng He Kong
Eng Sing Lee
Wee Shiong Lim
Sai Zhen Sim
Bryan Yijia Tan
Matthew Rong Jie Tay
Jong Moon Kim
Poo Lee Ong
Lay Wai Khin
Chin Jung Wong
Michael Gui Jie Yam
Justin Linghui Chew
Alvin Wai Kit Tan
Ananda Sidarta
Emily Yee
Karen Sui Geok Chua
author_sort Keng He Kong
collection DOAJ
description Introduction Sarcopenia and frailty have been identified as negative predictors of health outcomes. Patients with stroke, traumatic brain injury (TBI), knee osteoarthritis (OA) and breast cancer commonly experience low physical activity levels in the chronic phase of recovery. This prospective study aims to explore the feasibility of multimodal screening and longitudinal tracking of various biomarkers from the acute to chronic phase of disease to determine the relationship with frailty outcomes.Methods and analysis A prospective longitudinal observational cohort study involving Asian populations is planned over 3 years. Enrolled participants with index conditions of acute stroke, TBI, knee OA and breast cancer will be recruited from rehabilitation hospitals and clinics and followed longitudinally. Reference thresholds from the Asian Working Group on Sarcopenia will be used. Variables include self-reported questionnaires, disease and comorbidity characteristics, anthropometric measurements, appetite questionnaires, muscle ultrasound (MUS), muscle/bone mass, blood biomarkers and markerless gait motion systems. In particular, physical performance (short physical performance battery and hand grip strength), sarcopenia (SARC-F questionnaire) and frailty assessment (FRAIL score, clinical frailty scale), four-region MUS, body composition analysis, dual X-ray absorptiometry, bone mineral densitometry, physical activity levels (International Physical Activity Questionnaire for the elderly [IPAQ-E], fitness trackers) and health-related quality of life assessment (EuroQoL-5D questionnaire five level [EQ5D-5L]) will be used. Blood biomarkers measuring metabolic health (eg, glycated haemoglobin, cholesterol, fasting glucose and 25-OH vitamin D) and inflammation (eg, Tumor Necrosis Factor-alpha [TNF-α] and Monocyte Chemoattractant Protein-1 [MCP-1]) will be measured at baseline. Data collection will take place at postrecruitment baseline (hospital admission), 1, 6 months, 12 months and 2 years postrecruitment (inpatient) and at postrecruitment baseline, 6 months, 12 months and 2 years postrecruitment (outpatient).Ethics and dissemination Ethical approval has been obtained from the National Healthcare Group Domain Specific Review Board (2023/00105). Findings will be disseminated through conference presentations and publication in scientific journals.Trial registeration number NCT06073106.
format Article
id doaj-art-2ee01307cf6441049444fb749e7a6515
institution Kabale University
issn 2044-6055
language English
publishDate 2025-05-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-2ee01307cf6441049444fb749e7a65152025-08-20T03:53:52ZengBMJ Publishing GroupBMJ Open2044-60552025-05-0115510.1136/bmjopen-2024-094279Targeting osteosarcopenia and multimorbidity for frailty prevention through identification and deep phenotyping methods in healthy ageing and high-burden disease cohorts (OPTIMA-C): a longitudinal observational cohort study protocol for neuromusculoskeletal muscle healthKeng He Kong0Eng Sing Lee1Wee Shiong Lim2Sai Zhen Sim3Bryan Yijia Tan4Matthew Rong Jie Tay5Jong Moon Kim6Poo Lee Ong7Lay Wai Khin8Chin Jung Wong9Michael Gui Jie Yam10Justin Linghui Chew11Alvin Wai Kit Tan12Ananda Sidarta13Emily Yee14Karen Sui Geok Chua15Lee Kong Chian School of Medicine, Nanyang Technological University, SingaporeClinical Research Unit, National Healthcare Group Polyclinics, SingaporeLee Kong Chian School of Medicine, Nanyang Technological University, SingaporeClinical Research Unit, National Healthcare Group Polyclinics, SingaporeLee Kong Chian School of Medicine, Nanyang Technological University, SingaporeInstitute of Rehabilitation Excellence, Tan Tock Seng Hospital Rehabilitation Centre, Tan Tock Seng Hospital, SingaporeYong Loo Lin School of Medicine, National University of Singapore, SingaporeInstitute of Rehabilitation Excellence, Tan Tock Seng Hospital Rehabilitation Centre, Tan Tock Seng Hospital, SingaporeClinical Research & Innovation Office, Tan Tock Seng Hospital, SingaporeInstitute of Rehabilitation Excellence, Tan Tock Seng Hospital Rehabilitation Centre, Tan Tock Seng Hospital, SingaporeDepartment of Orthopedic Surgery, Tan Tock Seng Hospital, SingaporeInstitute of Geriatrics and Active Aging, Tan Tock Seng Hospital, SingaporeDepartment of Endocrinology, Tan Tock Seng Hospital, SingaporeRehabilitation Research Institute of Singapore, Nanyang Technological University, SingaporeInstitute of Rehabilitation Excellence, Tan Tock Seng Hospital Rehabilitation Centre, Tan Tock Seng Hospital, SingaporeInstitute of Rehabilitation Excellence, Tan Tock Seng Hospital Rehabilitation Centre, Tan Tock Seng Hospital, SingaporeIntroduction Sarcopenia and frailty have been identified as negative predictors of health outcomes. Patients with stroke, traumatic brain injury (TBI), knee osteoarthritis (OA) and breast cancer commonly experience low physical activity levels in the chronic phase of recovery. This prospective study aims to explore the feasibility of multimodal screening and longitudinal tracking of various biomarkers from the acute to chronic phase of disease to determine the relationship with frailty outcomes.Methods and analysis A prospective longitudinal observational cohort study involving Asian populations is planned over 3 years. Enrolled participants with index conditions of acute stroke, TBI, knee OA and breast cancer will be recruited from rehabilitation hospitals and clinics and followed longitudinally. Reference thresholds from the Asian Working Group on Sarcopenia will be used. Variables include self-reported questionnaires, disease and comorbidity characteristics, anthropometric measurements, appetite questionnaires, muscle ultrasound (MUS), muscle/bone mass, blood biomarkers and markerless gait motion systems. In particular, physical performance (short physical performance battery and hand grip strength), sarcopenia (SARC-F questionnaire) and frailty assessment (FRAIL score, clinical frailty scale), four-region MUS, body composition analysis, dual X-ray absorptiometry, bone mineral densitometry, physical activity levels (International Physical Activity Questionnaire for the elderly [IPAQ-E], fitness trackers) and health-related quality of life assessment (EuroQoL-5D questionnaire five level [EQ5D-5L]) will be used. Blood biomarkers measuring metabolic health (eg, glycated haemoglobin, cholesterol, fasting glucose and 25-OH vitamin D) and inflammation (eg, Tumor Necrosis Factor-alpha [TNF-α] and Monocyte Chemoattractant Protein-1 [MCP-1]) will be measured at baseline. Data collection will take place at postrecruitment baseline (hospital admission), 1, 6 months, 12 months and 2 years postrecruitment (inpatient) and at postrecruitment baseline, 6 months, 12 months and 2 years postrecruitment (outpatient).Ethics and dissemination Ethical approval has been obtained from the National Healthcare Group Domain Specific Review Board (2023/00105). Findings will be disseminated through conference presentations and publication in scientific journals.Trial registeration number NCT06073106.https://bmjopen.bmj.com/content/15/5/e094279.full
spellingShingle Keng He Kong
Eng Sing Lee
Wee Shiong Lim
Sai Zhen Sim
Bryan Yijia Tan
Matthew Rong Jie Tay
Jong Moon Kim
Poo Lee Ong
Lay Wai Khin
Chin Jung Wong
Michael Gui Jie Yam
Justin Linghui Chew
Alvin Wai Kit Tan
Ananda Sidarta
Emily Yee
Karen Sui Geok Chua
Targeting osteosarcopenia and multimorbidity for frailty prevention through identification and deep phenotyping methods in healthy ageing and high-burden disease cohorts (OPTIMA-C): a longitudinal observational cohort study protocol for neuromusculoskeletal muscle health
BMJ Open
title Targeting osteosarcopenia and multimorbidity for frailty prevention through identification and deep phenotyping methods in healthy ageing and high-burden disease cohorts (OPTIMA-C): a longitudinal observational cohort study protocol for neuromusculoskeletal muscle health
title_full Targeting osteosarcopenia and multimorbidity for frailty prevention through identification and deep phenotyping methods in healthy ageing and high-burden disease cohorts (OPTIMA-C): a longitudinal observational cohort study protocol for neuromusculoskeletal muscle health
title_fullStr Targeting osteosarcopenia and multimorbidity for frailty prevention through identification and deep phenotyping methods in healthy ageing and high-burden disease cohorts (OPTIMA-C): a longitudinal observational cohort study protocol for neuromusculoskeletal muscle health
title_full_unstemmed Targeting osteosarcopenia and multimorbidity for frailty prevention through identification and deep phenotyping methods in healthy ageing and high-burden disease cohorts (OPTIMA-C): a longitudinal observational cohort study protocol for neuromusculoskeletal muscle health
title_short Targeting osteosarcopenia and multimorbidity for frailty prevention through identification and deep phenotyping methods in healthy ageing and high-burden disease cohorts (OPTIMA-C): a longitudinal observational cohort study protocol for neuromusculoskeletal muscle health
title_sort targeting osteosarcopenia and multimorbidity for frailty prevention through identification and deep phenotyping methods in healthy ageing and high burden disease cohorts optima c a longitudinal observational cohort study protocol for neuromusculoskeletal muscle health
url https://bmjopen.bmj.com/content/15/5/e094279.full
work_keys_str_mv AT kenghekong targetingosteosarcopeniaandmultimorbidityforfrailtypreventionthroughidentificationanddeepphenotypingmethodsinhealthyageingandhighburdendiseasecohortsoptimacalongitudinalobservationalcohortstudyprotocolforneuromusculoskeletalmusclehealth
AT engsinglee targetingosteosarcopeniaandmultimorbidityforfrailtypreventionthroughidentificationanddeepphenotypingmethodsinhealthyageingandhighburdendiseasecohortsoptimacalongitudinalobservationalcohortstudyprotocolforneuromusculoskeletalmusclehealth
AT weeshionglim targetingosteosarcopeniaandmultimorbidityforfrailtypreventionthroughidentificationanddeepphenotypingmethodsinhealthyageingandhighburdendiseasecohortsoptimacalongitudinalobservationalcohortstudyprotocolforneuromusculoskeletalmusclehealth
AT saizhensim targetingosteosarcopeniaandmultimorbidityforfrailtypreventionthroughidentificationanddeepphenotypingmethodsinhealthyageingandhighburdendiseasecohortsoptimacalongitudinalobservationalcohortstudyprotocolforneuromusculoskeletalmusclehealth
AT bryanyijiatan targetingosteosarcopeniaandmultimorbidityforfrailtypreventionthroughidentificationanddeepphenotypingmethodsinhealthyageingandhighburdendiseasecohortsoptimacalongitudinalobservationalcohortstudyprotocolforneuromusculoskeletalmusclehealth
AT matthewrongjietay targetingosteosarcopeniaandmultimorbidityforfrailtypreventionthroughidentificationanddeepphenotypingmethodsinhealthyageingandhighburdendiseasecohortsoptimacalongitudinalobservationalcohortstudyprotocolforneuromusculoskeletalmusclehealth
AT jongmoonkim targetingosteosarcopeniaandmultimorbidityforfrailtypreventionthroughidentificationanddeepphenotypingmethodsinhealthyageingandhighburdendiseasecohortsoptimacalongitudinalobservationalcohortstudyprotocolforneuromusculoskeletalmusclehealth
AT pooleeong targetingosteosarcopeniaandmultimorbidityforfrailtypreventionthroughidentificationanddeepphenotypingmethodsinhealthyageingandhighburdendiseasecohortsoptimacalongitudinalobservationalcohortstudyprotocolforneuromusculoskeletalmusclehealth
AT laywaikhin targetingosteosarcopeniaandmultimorbidityforfrailtypreventionthroughidentificationanddeepphenotypingmethodsinhealthyageingandhighburdendiseasecohortsoptimacalongitudinalobservationalcohortstudyprotocolforneuromusculoskeletalmusclehealth
AT chinjungwong targetingosteosarcopeniaandmultimorbidityforfrailtypreventionthroughidentificationanddeepphenotypingmethodsinhealthyageingandhighburdendiseasecohortsoptimacalongitudinalobservationalcohortstudyprotocolforneuromusculoskeletalmusclehealth
AT michaelguijieyam targetingosteosarcopeniaandmultimorbidityforfrailtypreventionthroughidentificationanddeepphenotypingmethodsinhealthyageingandhighburdendiseasecohortsoptimacalongitudinalobservationalcohortstudyprotocolforneuromusculoskeletalmusclehealth
AT justinlinghuichew targetingosteosarcopeniaandmultimorbidityforfrailtypreventionthroughidentificationanddeepphenotypingmethodsinhealthyageingandhighburdendiseasecohortsoptimacalongitudinalobservationalcohortstudyprotocolforneuromusculoskeletalmusclehealth
AT alvinwaikittan targetingosteosarcopeniaandmultimorbidityforfrailtypreventionthroughidentificationanddeepphenotypingmethodsinhealthyageingandhighburdendiseasecohortsoptimacalongitudinalobservationalcohortstudyprotocolforneuromusculoskeletalmusclehealth
AT anandasidarta targetingosteosarcopeniaandmultimorbidityforfrailtypreventionthroughidentificationanddeepphenotypingmethodsinhealthyageingandhighburdendiseasecohortsoptimacalongitudinalobservationalcohortstudyprotocolforneuromusculoskeletalmusclehealth
AT emilyyee targetingosteosarcopeniaandmultimorbidityforfrailtypreventionthroughidentificationanddeepphenotypingmethodsinhealthyageingandhighburdendiseasecohortsoptimacalongitudinalobservationalcohortstudyprotocolforneuromusculoskeletalmusclehealth
AT karensuigeokchua targetingosteosarcopeniaandmultimorbidityforfrailtypreventionthroughidentificationanddeepphenotypingmethodsinhealthyageingandhighburdendiseasecohortsoptimacalongitudinalobservationalcohortstudyprotocolforneuromusculoskeletalmusclehealth